A detailed history of Chicago Trust CO Na transactions in Eli Lilly & CO stock. As of the latest transaction made, Chicago Trust CO Na holds 6,781 shares of LLY stock, worth $5.4 Million. This represents 1.28% of its overall portfolio holdings.

Number of Shares
6,781
Previous 6,389 6.14%
Holding current value
$5.4 Million
Previous $5.78 Million 3.86%
% of portfolio
1.28%
Previous 1.41%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

BUY
$772.14 - $960.02 $302,678 - $376,327
392 Added 6.14%
6,781 $6.01 Million
Q2 2024

Jul 11, 2024

BUY
$724.87 - $909.04 $120,328 - $150,900
166 Added 2.67%
6,389 $5.78 Million
Q1 2024

Apr 12, 2024

BUY
$592.2 - $792.28 $296,100 - $396,140
500 Added 8.74%
6,223 $4.84 Million
Q4 2023

Jan 16, 2024

SELL
$525.19 - $619.13 $222,680 - $262,511
-424 Reduced 6.9%
5,723 $3.34 Million
Q3 2023

Oct 27, 2023

BUY
$434.7 - $599.3 $30,863 - $42,550
71 Added 1.17%
6,147 $3.3 Million
Q2 2023

Jul 19, 2023

SELL
$350.74 - $468.98 $16,835 - $22,511
-48 Reduced 0.78%
6,076 $2.85 Million
Q1 2023

Apr 11, 2023

BUY
$310.63 - $364.82 $6,523 - $7,661
21 Added 0.34%
6,124 $2.1 Million
Q4 2022

Jan 12, 2023

SELL
$321.55 - $374.67 $29,261 - $34,094
-91 Reduced 1.47%
6,103 $2.23 Million
Q3 2022

Oct 13, 2022

SELL
$296.48 - $337.87 $125,114 - $142,581
-422 Reduced 6.38%
6,194 $2 Million
Q2 2022

Aug 03, 2022

SELL
$278.73 - $327.27 $49,335 - $57,926
-177 Reduced 2.61%
6,616 $2.15 Million
Q1 2022

Apr 12, 2022

SELL
$234.69 - $291.66 $56,090 - $69,706
-239 Reduced 3.4%
6,793 $1.95 Million
Q4 2021

Jan 18, 2022

BUY
$224.85 - $279.04 $182,128 - $226,022
810 Added 13.02%
7,032 $1.94 Million
Q3 2021

Oct 13, 2021

BUY
$221.6 - $272.71 $99,720 - $122,719
450 Added 7.8%
6,222 $1.44 Million
Q2 2021

Jul 21, 2021

BUY
$180.55 - $233.54 $42,429 - $54,881
235 Added 4.24%
5,772 $1.33 Million
Q1 2021

Apr 12, 2021

SELL
$164.32 - $212.72 $42,558 - $55,094
-259 Reduced 4.47%
5,537 $1.04 Million
Q4 2020

Jan 28, 2021

BUY
$130.46 - $172.63 $15,394 - $20,370
118 Added 2.08%
5,796 $978,000
Q3 2020

Oct 08, 2020

BUY
$146.22 - $169.13 $164,205 - $189,932
1,123 Added 24.65%
5,678 $841,000
Q2 2020

Jul 13, 2020

SELL
$136.42 - $164.18 $8,185 - $9,850
-60 Reduced 1.3%
4,555 $747,000
Q1 2020

Apr 07, 2020

SELL
$119.05 - $147.35 $5,357 - $6,630
-45 Reduced 0.97%
4,615 $641,000
Q3 2019

Oct 09, 2019

SELL
$106.79 - $116.16 $1,922 - $2,090
-18 Reduced 0.38%
4,660 $521,000
Q1 2019

Apr 10, 2019

SELL
$111.31 - $131.02 $14,470 - $17,032
-130 Reduced 2.7%
4,678 $607,000
Q4 2018

Jan 09, 2019

BUY
$105.9 - $118.64 $88,744 - $99,420
838 Added 21.11%
4,808 $556,000
Q3 2018

Oct 10, 2018

BUY
$85.86 - $107.31 $2,146 - $2,682
25 Added 0.63%
3,970 $426,000
Q2 2018

Jul 12, 2018

BUY
$75.7 - $86.88 $9,841 - $11,294
130 Added 3.41%
3,945 $337,000
Q1 2018

May 11, 2018

BUY
$74.21 - $87.6 $27,828 - $32,850
375 Added 10.9%
3,815 $295,000
Q3 2017

Oct 16, 2017

BUY
$77.07 - $85.54 $265,120 - $294,257
3,440
3,440 $294,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Chicago Trust CO Na Portfolio

Follow Chicago Trust CO Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chicago Trust CO Na, based on Form 13F filings with the SEC.

News

Stay updated on Chicago Trust CO Na with notifications on news.